TG Therapeutics Stock Options Expiring on 24th of January

TGTX Stock  USD 29.55  0.41  1.41%   
TG Therapeutics' latest option contracts expiring on January 24th 2025 are carrying combined implied volatility of 1.16 with a put-to-call open interest ratio of 0.58 over 57 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on January 24th 2025. The total put volume is at 144, with calls trading at the volume of 798. This yields a 0.18 put-to-call volume ratio.

Open Interest Against January 24th 2025 Option Contracts

TG Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in TG Therapeutics' lending market. For example, when TG Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on TG Therapeutics, he or she must hedge the risk by shorting TG Therapeutics stock over its option's life.
The chart above shows TG Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. TG Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for TG Therapeutics' option, there is no secondary market available for investors to trade.

TG Therapeutics Maximum Pain Price Across 2025-01-24 Option Contracts

Max pain occurs when TG Therapeutics' market makers reach a net positive position across all TG Therapeutics' options at a strike price where option holders stand to lose the most money. By contrast, TG Therapeutics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.

TG Therapeutics In The Money Call Balance

When TG Therapeutics' strike price is surpassing the current stock price, the option contract against TG Therapeutics stock is said to be in the money. When it comes to buying TG Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on TG Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

TGTX Current Options Market Mood

TG Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps TGTX Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most TG Therapeutics' options investors are not very successful. TG Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current TGTX contract

Base on the Rule 16, the options market is currently suggesting that TG Therapeutics will have an average daily up or down price movement of about 0.0725% per day over the life of the 2025-01-24 option contract. With TG Therapeutics trading at USD 29.55, that is roughly USD 0.0214. If you think that the market is fully incorporating TG Therapeutics' daily price movement you should consider buying TG Therapeutics options at the current volatility level of 1.16%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  

TG Therapeutics Option Chain

When TG Therapeutics' strike price is surpassing the current stock price, the option contract against TG Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
TG Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on TGTX. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for TGTX. It also shows strike prices and maturity days for a TG Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
TGTX250124C00025000425.04.2 - 4.94.85In
Call
TGTX250124C000280004528.01.75 - 2.21.4In
Call
TGTX250124C00027500627.52.05 - 2.52.65In
Call
TGTX250124C000295002029.50.85 - 1.30.75Out
Call
TGTX250124C000290001029.00.0 - 1.551.1In
Call
TGTX250124C000285004828.51.3 - 1.92.75In
Call
TGTX250124C000310007931.00.1 - 0.50.4Out
Call
TGTX250124C000305007230.50.45 - 0.750.4Out
Call
TGTX250124C0003000033130.00.65 - 0.80.7Out
Call
TGTX250124C000330001733.00.1 - 0.30.2Out
Call
TGTX250124C00032500332.50.0 - 0.350.1Out
Call
TGTX250124C0003200054032.00.15 - 0.40.16Out
Call
TGTX250124C00031500631.50.25 - 0.450.3Out
Call
TGTX250124C00035500135.50.0 - 0.50.35Out
Call
TGTX250124C0003500010035.00.1 - 0.250.1Out
Call
TGTX250124C000345003134.50.0 - 0.50.6Out
Call
TGTX250124C00034000534.00.0 - 0.20.7Out
Call
TGTX250124C000370001037.00.0 - 0.50.17Out
Call
TGTX250124C00036500136.50.0 - 0.71.9Out
Call
TGTX250124C00036000236.00.0 - 2.150.08Out
Call
TGTX250124C00039000039.00.0 - 1.351.35Out
Call
TGTX250124C00038500038.50.0 - 1.351.35Out
Call
TGTX250124C00038000138.00.0 - 1.351.35Out
Call
TGTX250124C0004000059340.00.0 - 0.250.15Out
Call
TGTX250124C000410001141.00.0 - 1.350.71Out
Call
TGTX250124C000420001042.00.0 - 1.151.28Out
Call
TGTX250124C00043000043.00.0 - 1.351.35Out
Call
TGTX250124C00044000044.00.0 - 2.152.15Out
Call
TGTX250124C000450001445.00.0 - 1.350.9Out
Call
TGTX250124C0005000016650.00.0 - 0.250.3Out
 Put
TGTX250124P000250004025.00.0 - 2.150.13Out
 Put
TGTX250124P000270005627.00.0 - 0.251.6Out
 Put
TGTX250124P00026500226.50.0 - 0.151.55Out
 Put
TGTX250124P000260004426.00.0 - 0.150.1Out
 Put
TGTX250124P0002900059729.00.45 - 0.850.85Out
 Put
TGTX250124P000285002728.50.35 - 0.50.45Out
 Put
TGTX250124P000280002528.00.15 - 0.50.3Out
 Put
TGTX250124P00027500327.50.05 - 0.40.35Out
 Put
TGTX250124P000310009531.01.55 - 2.12.25In
 Put
TGTX250124P0003050024230.51.25 - 1.90.95In
 Put
TGTX250124P000300005230.01.0 - 1.21.1In
 Put
TGTX250124P000295003629.50.65 - 1.250.85Out
 Put
TGTX250124P00032500132.52.75 - 3.43.38In
 Put
TGTX250124P00032000632.02.3 - 2.853.19In
 Put
TGTX250124P00033500533.53.7 - 4.34.65In
 Put
TGTX250124P00035000535.05.2 - 5.95.2In
 Put
TGTX250124P00036000536.06.2 - 6.86.27In
 Put
TGTX250124P00039000039.09.3 - 9.79.3In
 Put
TGTX250124P00038500038.58.8 - 9.28.8In
 Put
TGTX250124P00038000038.08.3 - 8.78.3In
 Put
TGTX250124P00040000040.010.3 - 10.710.3In
 Put
TGTX250124P00041000041.011.3 - 11.711.3In
 Put
TGTX250124P00042000042.012.3 - 12.712.3In
 Put
TGTX250124P00043000043.013.3 - 13.713.3In
 Put
TGTX250124P00044000044.014.3 - 14.714.3In
 Put
TGTX250124P00045000045.014.5 - 15.914.5In
 Put
TGTX250124P00050000050.020.3 - 20.720.3In

TG Therapeutics Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

TG Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

TGTX Total Stockholder Equity

Total Stockholder Equity

151.67 Million

At this time, TG Therapeutics' Total Stockholder Equity is fairly stable compared to the past year.

TG Therapeutics Corporate Executives

Elected by the shareholders, the TG Therapeutics' board of directors comprises two types of representatives: TG Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TGTX. The board's role is to monitor TG Therapeutics' management team and ensure that shareholders' interests are well served. TG Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TG Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Sean CPACorporate CFOProfile

Additional Tools for TGTX Stock Analysis

When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.